Advancing Cell Engineering

As molecule complexity and product quality expectations increase, so does the pressure to accelerate time-to-market and cut manufacturing costs. To tackle these challenges, optimizing current biopharmaceutical production systems is essential. Sartorius Corporate Research is advancing genome editing tools and workflows, along with enhanced bioinformatics and data analysis techniques. By leveraging these cutting-edge technologies, we create engineered production cell lines with reduced cell-related impurities and significantly improved predictability, growth, productivity, and product quality. These innovative strategies have the power to transform and propel the manufacturing of modern biopharmaceuticals.